26.08.2022 • News

Arxada Expands at Visp to Continue Supplying DSM

Swiss specialty chemicals company Arxada said it will invest 20 million Swiss francs to expand production at its Visp site following the extension of a long-term supply partnership with DSM.

Arxada supplies niacin and various other nutritional ingredients to DSM’s vitamin and aroma ingredients business in neighboring Visp-Lalden. The company will also make further investments to cut Visp’s carbon footprint so as to help meet both firms’ sustainability commitments.

“This significant new investment in our Visp facility secures the site’s long-term future, helping to fuel our future growth, and demonstrates our clear commitment to sustainability and reducing our carbon footprint,” said Antje Gerber, Arxada’s president, specialty products solutions.

Arxada did not give a start-up date for the expansion. The Basel-based firm said it had already made a “significant” investment at the site last year to reduce greenhouse gas emissions.

Author: Elaine Burridge, Freelance Journalist

©lichtmeister/Shutterstock
©lichtmeister/Shutterstock

Company

Logo:

Arxada AG


4052 Basel
Switzerland

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read